TY - JOUR
T1 - Public health oncology
T2 - A framework for progress in low- and middle-income countries
AU - Love, R. R.
AU - Ginsburg, O. M.
AU - Coleman, C. N.
N1 - Funding Information:
International Breast Cancer Research Foundation; NIH/NCI (Grant # CA097375); Susan B. Komen Foundation for the Cure; Breast Cancer Research Foundation. These funding sources have played no role in the contents of this communication. (There are no specific grant numbers for the Komen or BCRF funding which have been provided over years.)
PY - 2012/12
Y1 - 2012/12
N2 - Background: The problems of cancer are increasing in low- and middle-income countries (LMCs), which now have significant majorities of the global case and mortality burdens. The professional oncology community is being increasingly called upon to define pragmatic and realistic approaches to these problems. Patients and methods: Focusing on mortality and case burden outcomes defines public health oncology or population-affecting cancer medicine. We use this focus to consider practical approaches. Results: The greatest cancer burdens are in Asia. A public health oncology perspective mandates: first, addressing the major and social challenges of cancer medicine for populations: human rights, health systems, corruption, and our limited knowledge base for value-conscious interventions. Second, adoption of evolving concepts and models for sustainable development in LMCs. Third, clear and realistic statements of action and inaction affecting populations, grounded in our best cancer science, and attention to these. Finally, framing the goals and challenges for population-affecting cancer medicine requires a change in paradigm from historical top-down models of technology transfer, to one which is community-grounded and local-evidence based. Conclusion: Public health oncology perspectives define clear focus for much needed research on country-specific practical approaches to cancer control.
AB - Background: The problems of cancer are increasing in low- and middle-income countries (LMCs), which now have significant majorities of the global case and mortality burdens. The professional oncology community is being increasingly called upon to define pragmatic and realistic approaches to these problems. Patients and methods: Focusing on mortality and case burden outcomes defines public health oncology or population-affecting cancer medicine. We use this focus to consider practical approaches. Results: The greatest cancer burdens are in Asia. A public health oncology perspective mandates: first, addressing the major and social challenges of cancer medicine for populations: human rights, health systems, corruption, and our limited knowledge base for value-conscious interventions. Second, adoption of evolving concepts and models for sustainable development in LMCs. Third, clear and realistic statements of action and inaction affecting populations, grounded in our best cancer science, and attention to these. Finally, framing the goals and challenges for population-affecting cancer medicine requires a change in paradigm from historical top-down models of technology transfer, to one which is community-grounded and local-evidence based. Conclusion: Public health oncology perspectives define clear focus for much needed research on country-specific practical approaches to cancer control.
KW - Cancer in low-income countries
KW - Public health oncology
UR - http://www.scopus.com/inward/record.url?scp=84869806930&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84869806930&partnerID=8YFLogxK
U2 - 10.1093/annonc/mds473
DO - 10.1093/annonc/mds473
M3 - Article
C2 - 23087162
AN - SCOPUS:84869806930
SN - 0923-7534
VL - 23
SP - 3040
EP - 3045
JO - Annals of Oncology
JF - Annals of Oncology
IS - 12
M1 - mds473
ER -